ヒト造血器型プロスタグランジンD合成酵素の構造に基づく阻害剤の開発

  • 井上 豪
    大阪大学大学院工学研究科物質化学専攻
  • 甲斐 泰
    大阪大学大学院工学研究科物質化学専攻
  • 裏出 良博
    (財)大阪バイオサイエンス研究所分子行動生物学部門

書誌事項

タイトル別名
  • Structure-Based Inhibitor Design of Human Hematopoietic Prostaglandin D Synthase
  • ヒト ゾウケツキガタ プロスタグランジン D ゴウセイ コウソ ノ コウゾウ ニ モトヅク ソガイザイ ノ カイハツ

この論文をさがす

抄録

Hematopoietic prostaglandin (PG) D synthase (H-PGDS) catalyzes the isomerization of PGH2 to PGD2, an allergic and inflammatory mediator, in the presence of glutathione (GSH) in mast and Th2 cells. We have determined the crystal structures of the Ca2+- and Mg2+- bound forms of human H-PGDS, revealing the metal activation mechanism, in which Ca2+ or Mg2+ increases its activity to150% of the basal level, with half maximum effective concentrations of 400μM for Ca2+ and 50μM for Mg2+. Especially, we found a four-fold reduction in the Km of the enzyme for GSH in the presence of Mg2+. We also performed the X-ray crystallographic studies of the complex crystals with some inhibitors. Among them HQL-79 is effect with orally treatment with IC50 value of 5.8μM, and three new inhibitors derived from HQL-79 were designed. The complex structures with these inhibitors provide a novel insight into the anti-allergic drug designs.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (24)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ